Picodya Technologies

Picodya Technologies Overview

Picodya introduces game-changing technology with the proven potential to empower diagnostics access worldwide. Picodya's B-Matrix, microfluidic lab-on-a-chip platform redefines diagnostics, supports simultaneous hybrid testing for both molecular and immunoassays with multiplexed syndromic panels for various sample types. Its innovative multi-use consumables utilization allows for massive cost reduction while the minimal sample volume offers less invasive patients’ experience. The system unique and modular design supports diverse clinical settings anywhere from a large hospital systems’ laboratory through urgent care settings and physician offices as well as emerging settings such as airports, pharmacies and patients’ homes.

Cumulative Funding Raised Over Time ($)

Latest News

Jan 9, 2024 · www.medicaldevice-network.com

growth-positive

Picodya diagnostics system adopted through NIH pandemic initiative

Israel-based in vitro diagnostics firm, Picodya, has announced that its B-Matrix multiplexed point-of-care testing systems are being implemented in government laboratories across the US. The adoption by the National Institute of Health (NIH) is part of a bid to establish a backlog of immunobiological countermeasures in preparation for another pandemic. The NIH initiative, named PREMISE and headed up by the National Institute of Allergy and Infectious Diseases (NIAID), launched in 2021 and saw the body working alongside Picodya to install the B-Matrix systems at NIAID Vaccine Research Centers and laboratories.

PartnersExpand

Apr 21, 2023 · www.hospimedica.com

Game Changing Immunoassay Platform Redefines POC Diagnostics on Every Level

Feb 4, 2021 · en.globes.co.il

growth-positive

Covid brings Picodya's rapid diagnostics out from under the radar

Kibbutz Hatzerim, known for its irrigation technology company Netafim, has diversified its investments and is now involved in medical diagnostics through its investment in Picodya. Picodya, led by Tzvika Barkai, has developed a prototype for a diagnostic product that can perform multiple tests on a patients sample simultaneously, at a lower cost. The product has undergone feasibility tests for twenty types of symptoms and diseases and is expected to reach the market in 2022-2023. Kibbutz Hatzerim provides the organizational and management framework for Picodya, which recently completed a $10 million fundraising round led by SIBF. The kibbutz aims to become an industrial product company in the future.

InvestmentExpand

Aug 11, 2020 · www.calcalistech.com

growth-positive

Hatzerim-based Picodya raises $10 million for rapid diagnostics innovation

Picodya, an Israeli company, is on the verge of completing a $10 million funding round led by SIBF. The company has developed an in vitro diagnostics platform named B-Matrix, which can conduct tests and analyses for multiple patients simultaneously. The goal is to deploy the product at the point of care to reduce the time and manpower required for blood tests. Picodya has received grants from the Israel Innovation Authority and its prototype will be tested by The Israel Institute for Biological Research. The funding round is part of preparations for a larger round aimed at raising tens of millions of dollars in the next year to 18 months.

Investment

Aug 11, 2020 · www.web24.news

Neutral

https://www.web24.news/u/2020/08/an-israeli-company-can-diagnose-covid-19-in-multiple-patients-simultaneously-in-just-15-minutes.html

The webpage was created by the domain owner using Sedos Domain Parking service. Sedo, however, maintains no relationship with third party advertisers and does not control or endorse any specific service or trade mark.

Funding

Team Members

4

Employees: 11-50

Web & Social Links

Locations

Haim Holtsman St 2, Ness Ziona, Israel

Photos & Videos

2 item(s)

Picodya Technologies Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info